HomeFile

File

View Category
Acute coronary syndromes

Multiple vs. Culprit vessel MI in Cardiogenic Shock: Anything New?

The Shock Trial, the one that set revascularization as the standard strategy to treat all STEMI and...
solaci -
Learn More
Coronary disease

Estimating the Risk of Infection for Healthcare Personnel

Roughly one out of every 100 healthcare workers at hospitals receiving COVID-19 patients become infected. Statistics are not...
solaci -
Learn More
Acute coronary syndromes

Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of...
solaci -
Learn More
Acute coronary syndromes

Bleeding and Cardiogenic Shock: An “Unholy Alliance”?

Courtesy of Dr. Carlos Fava. Mortality in acute myocardial infarction (MI) with cardiogenic shock (CS) has been reduced over...
solaci -
Learn More
Acute coronary syndromes

Priorities in the Cath Lab to Escape COVID-19 Tsunami

The pandemic tsunami of COVID-19 has hit all cath lab services, especially those performing primary PCI.  Passively waiting...
solaci -
Learn More
Acute coronary syndromes

Covid-19 and Unaccounted Collateral Damage

Dr Metzler and collaborators carried out a retrospective search to find out the impact of the Covid-19...
solaci -
Learn More
Structural heart disease

Frailty and Bleeding: Impact on Aortic Valve Replacement

Courtesy of Dr. Carlos Fava. We are well aware that both transcatheter aortic valve replacement (TAVR) and surgical...
solaci -
Learn More
Structural heart disease

Leaflet Thickening and Immobility in Evolut Low Risk

Leaflet thickening and immobility caused by thrombosis have been reported for both surgical and transcatheter bioprostheses. This phenomenon...
solaci -
Learn More